Innovative Diagnostics
Grabels, Occitanie Innovative Diagnostics
- UEI
- U21UNJ3ZMSL7
- CAGE
- FAZD6
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Innovative Diagnostics
U21UNJ3ZMSL7
- Id Vet Inc. C99ZPMAHLPC5
-
Innovative Diagnostics
U21UNJ3ZMSL7
- SAM.gov registration date
- Physical address
- 310 Rue Louis Pasteur ii, 34790 Grabels, France
- Website
- innovative-diagnostics.com
- Founded
- 2004
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Elisa kits for use in the detection of H5 highly pathogenic avian influenza in swine and cattle hosts. | Central Program Planning Coordination and Support | $119,325 | |
| Idvet innovative diagnostics glanders double antigen elisa test kits | Marketing and Regulatory Programs Business Services | $0 | |
| This is a to/do order against IDIQ 12639523D0096 for 57149/122779 idvet glanders double antigen elisa test kits… | Marketing and Regulatory Programs Business Services | $40,313 | |
| This is a do/to order for 50 each of idvet glanders double antigen elisa test kits delivered to the address on the… | Marketing and Regulatory Programs Business Services | $80,625 |
About Innovative Diagnostics
Innovative Diagnostics is a for-profit veterinary diagnostic supplier headquartered in Grabels, France, that specializes in providing specialized diagnostic testing kits to support disease surveillance and animal health monitoring efforts within the United States federal government. The company maintains an active registration in SAM.gov through April 2026 and has established itself as a qualified supplier of advanced immunoassay-based detection technologies for the agricultural sector.
Innovative Diagnostics has secured multiple federal contract awards from the U.S. Department of Agriculture, specifically through its Animal and Plant Health Inspection Service (APHIS) divisions of Veterinary Services and the Midwest Area. The company's primary product offerings consist of ELISA (Enzyme-Linked Immunosorbent Assay) test kits designed for disease detection in livestock and poultry populations. Notably, the company has supplied IDVET Glanders Double Antigen ELISA test kits through three separate delivery orders valued at $80,625.00 (awarded March 18, 2025), $40,312.50 (awarded August 15, 2024), and $80,625.00 (awarded May 24, 2024), all issued under an underlying IDIQ contract with USDA Veterinary Services. Most recently, Innovative Diagnostics received a firm fixed-price purchase order valued at $119,324.50 from APHIS for ELISA kits designed to detect H5 Highly Pathogenic Avian Influenza exposure in swine and cattle hosts, with a performance period extending through September 29, 2026. All awards have been issued on a competitive basis with no set-aside designations, reflecting the company's technical capabilities and competitive positioning within the veterinary diagnostic market.
Innovative Diagnostics holds a single-award indefinite delivery, indefinite quantity (IDIQ) contract with USDA Veterinary Services (Contract ID 12639523D0096) valued at $903,000 with a five-year period of performance extending from September 2023 through August 2028. This foundational IDV contract was structured to provide recurring delivery orders for Glanda-5P ID Screen Glanders Double Antigen ELISA testing kits across five one-year ordering periods, establishing a standing offer mechanism that allows APHIS Veterinary Services to fulfill recurring diagnostic testing requirements on an as-needed basis while maintaining competitive pricing. The IDIQ structure has proven effective, as evidenced by the multiple delivery orders placed against it throughout the contract period, demonstrating the agency's continued reliance on Innovative Diagnostics' specialized expertise in providing critical veterinary disease screening technologies to support disease surveillance and detection missions.
Quick answers
What is Innovative Diagnostics's UEI?
Innovative Diagnostics's Unique Entity ID (UEI) in SAM.gov is U21UNJ3ZMSL7.
What is Innovative Diagnostics's CAGE code?
Innovative Diagnostics's CAGE code is FAZD6.
What is Innovative Diagnostics's primary NAICS code?
Innovative Diagnostics's primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Where is Innovative Diagnostics located?
Innovative Diagnostics's physical address in SAM.gov is 310 Rue Louis Pasteur ii, 34790 Grabels, France.
Is Innovative Diagnostics registered in SAM.gov?
Yes. Innovative Diagnostics's SAM.gov registration is active through April 2, 2027.
What is Innovative Diagnostics's most recent federal award?
Innovative Diagnostics's most recent federal contract award is Elisa kits for use in the detection of H5 highly pathogenic avian influenza in swine and cattle hosts (1232SA25P0580), from Central Program Planning Coordination and Support, on September 29, 2025.
On GovTribe
See Innovative Diagnostics's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors